Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

384 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Completed

A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

NCT04609826

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • CHU de Nice Hopital de l Archet Nice, France
  • Hopital Saint Louis Paris, France
  • Centre Hospitalier Universitaire (CHU) de Bordeaux Hopital HautLeveque Centre Francois Magendie Pessac, France
  • Institut Universitaire du Cancer Toulouse Oncopole Toulouse, France
View all 20 locations
View Trial Details
Completed

Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS

NCT03066648

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Oregon Health Sciences University Main Center Portland, Oregon, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Novartis Investigative Site Melbourne, Victoria, Australia
View Trial Details
Completed

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

NCT00588991

Conditions
Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +55 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details

Related conditions